Enovix Corp is trading at $8.48 (+6.3%), extending a multi-day recovery following a volatile reaction to its Q1 2026 earnings report.

  • The stock has trended steadily higher as investors reassess the quarterly update, reversing a sharp decline seen in after-hours trading immediately following the report.
  • Sentiment toward the name continues to improve, with the stock significantly outpacing the major indices which remain broadly flat today.
  • The price action suggests a stabilization in investor confidence as the market digests the company's latest financial results and forward-looking guidance.